{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:58:15Z","timestamp":1780707495663,"version":"3.54.1"},"reference-count":96,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002557","type":"journal-article","created":{"date-parts":[[2012,3,2]],"date-time":"2012-03-02T21:15:06Z","timestamp":1330722906000},"page":"e1002557","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Critical Role of Perforin-dependent CD8+ T Cell Immunity for Rapid Protective Vaccination in a Murine Model for Human Smallpox"],"prefix":"10.1371","volume":"8","author":[{"given":"Melanie","family":"Kremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Suezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asisa","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Frenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monir","family":"Majzoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Martin","family":"Hanschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Kalinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2009-06-227546","article-title":"Memories that last forever: strategies for optimizing vaccine T-cell memory.","volume":"115","author":"JD Ahlers","year":"2010","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/icb.2009.16","article-title":"Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.","volume":"87","author":"LE Brown","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/eji.200939550","article-title":"Generating memory with vaccination.","volume":"39","author":"F Castellino","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/654931","article-title":"Evaluation of Cytomegalovirus (CMV)-Specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.","volume":"202","author":"D Abate","year":"2010","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.","volume":"116","author":"T Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/nm1218","article-title":"The process development challenge for a new vaccine.","volume":"11","author":"BC Buckland","year":"2005","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nbt0910-910","article-title":"First-in-human clinical trials with vaccines - what regulators want.","volume":"28","author":"KB Goetz","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0264-410X(03)00074-4","article-title":"Novel generations of influenza vaccines.","volume":"21","author":"G Kemble","year":"2003","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.vaccine.2011.01.053","article-title":"Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis.","volume":"29","author":"L-y Wang","year":"2011","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.vaccine.2009.09.029","article-title":"Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals.","volume":"27","author":"CE Rupprecht","year":"2009","journal-title":"Vaccine"},{"key":"ref11","first-page":"1371","article-title":"Smallpox and its eradication","author":"F Fenner","year":"1988"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.","volume":"107","author":"AW Rimoin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1073\/pnas.0403600101","article-title":"Discovery of antivirals against smallpox.","volume":"101","author":"SC Harrison","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA.","volume":"3","author":"A Mayr","year":"1975","journal-title":"Infection"},{"key":"ref15","first-page":"375","article-title":"[The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)].","volume":"167","author":"A Mayr","year":"1978","journal-title":"Zentralbl Bakteriol B"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.","volume":"72","author":"H Meyer","year":"1991","journal-title":"J Gen Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.copbio.2004.09.001","article-title":"Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?","volume":"15","author":"I Drexler","year":"2004","journal-title":"Curr Opin Biotechnol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/156652308784049363","article-title":"The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer.","volume":"8","author":"CE Gomez","year":"2008","journal-title":"Curr Gene Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.70.6.3741-3752.1996","article-title":"Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.","volume":"70","author":"V Hirsch","year":"1996","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.09.4","article-title":"Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.","volume":"8","author":"GF Rimmelzwaan","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines.","volume":"7","author":"SR Rosenthal","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes.","volume":"89","author":"G Sutter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.","volume":"100","author":"IM Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.262668999","article-title":"Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.","volume":"100","author":"I Drexler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.","volume":"428","author":"PL Earl","year":"2004","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0264-410X(94)90341-7","article-title":"A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.","volume":"12","author":"G Sutter","year":"1994","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.","volume":"101","author":"LS Wyatt","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature04295","article-title":"Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.","volume":"439","author":"KJ Stittelaar","year":"2006","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005033481123","article-title":"Vaccinia vectors as candidate vaccines: The development of Modified Vaccinia Virus Ankara for antigen delivery.","volume":"3","author":"G Sutter","year":"2003","journal-title":"Curr Drug Targets Infect Disord"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2009.11.030","article-title":"A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.","volume":"28","author":"A von Krempelhuber","year":"2010","journal-title":"Vaccine"},{"key":"ref31","first-page":"129","article-title":"Progressive vaccinia in immunologically deficient individuals.","volume":"4","author":"VA Fulginiti","year":"1968","journal-title":"Birth Defects Orig Artic Ser"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.7326\/0003-4819-60-2-282","article-title":"Progressive vaccinia with normal antibodies. A case possibly due to deficient cellular immunity.","volume":"60","author":"CJ O'Connel","year":"1964","journal-title":"Ann Intern Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM198703123161106","article-title":"Disseminated Vaccinia in a military recruit with Human Immunodeficiency Virus (HIV) disease.","volume":"316","author":"RR Redfield","year":"1987","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1128\/JVI.78.8.3811-3816.2004","article-title":"Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells.","volume":"78","author":"RR Amara","year":"2004","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/JVI.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus.","volume":"70","author":"W Demkowicz Jr","year":"1996","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination.","volume":"9","author":"E Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox.","volume":"21","author":"TM Mack","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"ref38","first-page":"307","article-title":"The minimum protective level of antibodies in smallpox.","volume":"52","author":"JK Sarkar","year":"1975","journal-title":"Bull World Health Organ"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.","volume":"105","author":"PL Earl","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.","volume":"11","author":"Y Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/595565","article-title":"Postexposure immunization with Modified Vaccinia Virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.","volume":"199","author":"N Paran","year":"2009","journal-title":"J Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection.","volume":"118","author":"C Samuelsson","year":"2008","journal-title":"J Clin Invest"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1099\/vir.0.82068-0","article-title":"Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara.","volume":"87","author":"C Staib","year":"2006","journal-title":"J Gen Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e1000480","DOI":"10.1371\/journal.ppat.1000480","article-title":"Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2\u2013TLR6, MDA-5 and the NALP3 inflammasome.","volume":"5","author":"J Delaloye","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.20091472","article-title":"Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells.","volume":"206","author":"S Halle","year":"2009","journal-title":"J Exp Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1128\/JVI.01884-08","article-title":"Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.","volume":"83","author":"MH Lehmann","year":"2009","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1128\/JVI.01190-07","article-title":"Modified Vaccinia Virus Ankara induces Toll-Like Receptor-independent Type I Interferon responses.","volume":"81","author":"Z Waibler","year":"2007","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines.","volume":"201","author":"DC Tscharke","year":"2005","journal-title":"J Exp Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1128\/JVI.05334-11","article-title":"Gamma Interferon and Perforin Control the Strength, but Not the Hierarchy, of Immunodominance of an Antiviral CD8+ T Cell Response.","volume":"85","author":"S Remakus","year":"2011","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1073\/pnas.0402949101","article-title":"Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.","volume":"101","author":"G Chaudhri","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1371\/journal.ppat.0040030","article-title":"A role for NKG2D in NK cell\u2013mediated resistance to poxvirus disease.","volume":"4","author":"M Fang","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1084\/jem.20100282","article-title":"Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking.","volume":"207","author":"M Fang","year":"2010","journal-title":"J Exp Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.vaccine.2009.01.038","article-title":"Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.","volume":"27","author":"S Lustig","year":"2009","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/350423a0","article-title":"A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.","volume":"350","author":"D Kitamura","year":"1991","journal-title":"Nature"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/0092-8674(93)90644-6","article-title":"Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.","volume":"73","author":"H Gu","year":"1993","journal-title":"Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.yexcr.2006.08.019","article-title":"Immunodeficient mice have elevated numbers of NK cells in non-lymphoid tissues.","volume":"312","author":"MA Grundy","year":"2006","journal-title":"Exp Cell Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/ni0901-876","article-title":"Separable effector T cell populations specialized for B cell help or tissue inflammation.","volume":"2","author":"DJ Campbell","year":"2001","journal-title":"Nat Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coi.2006.03.003","article-title":"T helper cell effector fates - who, how and where?","volume":"18","author":"RL Reinhardt","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","article-title":"Molecular mechanisms regulating TH1 immune responses.","volume":"21","author":"SJ Szabo","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4049\/jimmunol.177.3.1406","article-title":"Cutting Edge: Cognate CD4 help promotes recruitment of antigen-specific CD8 T cells around dendritic cells.","volume":"177","author":"H Beuneu","year":"2006","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/rmv.381","article-title":"Cell-mediated cytotoxicity in recovery from poxvirus infections.","volume":"13","author":"A M\u00fcllbacher","year":"2003","journal-title":"Rev Med Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/JVI.73.2.1665-1667.1999","article-title":"Perforin is essential for control of Ectromelia virus but not related poxviruses in mice.","volume":"73","author":"A M\u00fcllbacher","year":"1999","journal-title":"J Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"e9659","DOI":"10.1371\/journal.pone.0009659","article-title":"Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice.","volume":"5","author":"H Lauterbach","year":"2010","journal-title":"PLoS ONE"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC.","volume":"458","author":"V Hornung","year":"2009","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1128\/JVI.00444-07","article-title":"Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.","volume":"81","author":"S Guerra","year":"2007","journal-title":"J Virol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-2427(94)05357-X","article-title":"Interferon induction in peripheral blood mononuclear leukocytes of man and farm animals by poxvirus vector candidates and some poxvirus constructs.","volume":"46","author":"M B\u00fcttner","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of Attenuated Modified Vaccinia Virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.","volume":"74","author":"JC Ramirez","year":"2000","journal-title":"J Virol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge.","volume":"25","author":"SE Frey","year":"2007","journal-title":"Vaccine"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1099\/vir.0.010553-0","article-title":"Evaluation of smallpox vaccines using variola neutralization.","volume":"90","author":"IK Damon","year":"2009","journal-title":"J Gen Virol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"14984","DOI":"10.1073\/pnas.0906554106","article-title":"T cell receptor sharing by cytotoxic T lymphocytes facilitates efficient virus control.","volume":"106","author":"G Chaudhri","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/eji.201040453","article-title":"Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion.","volume":"40","author":"T Frenz","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.175.10.6829","article-title":"Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus.","volume":"175","author":"M Fang","year":"2005","journal-title":"J Immunol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/JVI.00116-06","article-title":"Obligatory requirement for antibody in recovery from a primary poxvirus infection.","volume":"80","author":"G Chaudhri","year":"2006","journal-title":"J Virol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/JVI.00115-06","article-title":"Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.","volume":"80","author":"V Panchanathan","year":"2006","journal-title":"J Virol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1084\/jem.133.5.1074","article-title":"Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells.","volume":"133","author":"RV Blanden","year":"1971","journal-title":"J Exp Med"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"e1000249","DOI":"10.1371\/journal.ppat.1000249","article-title":"Surviving mousepox infection requires the complement system.","volume":"4","author":"EA Moulton","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/icb.2009.110","article-title":"Antiviral protection following immunization correlates with humoral but not cell-mediated immunity.","volume":"88","author":"V Panchanathan","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1073\/pnas.0701822104","article-title":"Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection.","volume":"104","author":"R-H Xu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","article-title":"Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.","volume":"10","author":"R Wittek","year":"2006","journal-title":"Int J Infect Dis"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1128\/JVI.01191-10","article-title":"N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.","volume":"85","author":"MS Gratz","year":"2011","journal-title":"J Virol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/eji.1830251209","article-title":"The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses.","volume":"25","author":"D Kagi","year":"1995","journal-title":"Eur J Immunol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T cell help in generating functional CD8 T cell memory.","volume":"300","author":"DJ Shedlock","year":"2003","journal-title":"Science"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","article-title":"Defective CD8 T cell memory following acute infection without CD4 T cell help.","volume":"300","author":"JC Sun","year":"2003","journal-title":"Science"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/JVI.01617-08","article-title":"Vaccinia Virus-mediated inhibition of Type I Interferon responses is a multifactorial process involving the soluble Type I Interferon receptor B18 and intracellular components.","volume":"83","author":"Z Waibler","year":"2009","journal-title":"J Virol"},{"key":"ref85","first-page":"51","article-title":"Live viral vectors: vaccinia virus.","volume":"87","author":"C Staib","year":"2003","journal-title":"Methods Mol Med"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes.","volume":"68","author":"P Mombaerts","year":"1992","journal-title":"Cell"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent Toll-Like receptor signaling pathway.","volume":"301","author":"M Yamamoto","year":"2003","journal-title":"Science"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1084\/jem.20060792","article-title":"Essential role of IPS-1 in innate immune responses against RNA viruses.","volume":"203","author":"H Kumar","year":"2006","journal-title":"J Exp Med"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/intimm\/5.6.647","article-title":"Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus.","volume":"5","author":"J Chen","year":"1993","journal-title":"Int Immunol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/328077a0","article-title":"Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells.","volume":"328","author":"RM Buller","year":"1987","journal-title":"Nature"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.4049\/jimmunol.125.6.2665","article-title":"IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.","volume":"125","author":"M Sarmiento","year":"1980","journal-title":"J Immunol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.4049\/jimmunol.137.12.3742","article-title":"The NK-1.1(\u2212) mouse: a model to study differentiation of murine NK cells.","volume":"137","author":"G Koo","year":"1986","journal-title":"J Immunol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.4049\/jimmunol.151.8.3971","article-title":"Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.","volume":"151","author":"M Gavin","year":"1993","journal-title":"J Immunol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/CDLI.11.2.406-410.2004","article-title":"Neutralization assay using a Modified Vaccinia Virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against Vaccinia Virus.","volume":"11","author":"A Cosma","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"766, 769","DOI":"10.2144\/02334bm10","article-title":"Pseudogene-free amplification of human GAPDH cDNA.","volume":"33","author":"MH Lehmann","year":"2002","journal-title":"Biotechniques"},{"key":"ref96","first-page":"365","article-title":"Primer3 on the WWW for general users and for biologist programmers.","volume":"132","author":"S Rozen","year":"2000","journal-title":"Methods Mol Biol"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T21:41:21Z","timestamp":1687297281000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002557"}},"subtitle":[],"editor":[{"given":"Michele","family":"Barry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":96,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002557","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}